Related Experiment Video
Updated: Jun 9, 2026
06:22
In Vivo Imaging of Cerebrospinal Fluid Transport through the Intact Mouse Skull using Fluorescence Macroscopy
Published on: July 29, 2019
Reviving Brain Waste Clearance: A Pharmacological Perspective on Glymphatic Dysfunction and AQP4 Modulation
Souvik Banerjee1, Shareen Singh1, Thakur Gurjeet Singh1
1Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, 140401, India.
Current Neuropharmacology
|June 8, 2026
Summary
The brain's glymphatic system clears waste, but declines with age and disease. Targeting aquaporin-4 (AQP4) channels and inflammation shows promise for enhancing brain clearance and neuroprotection.
Area of Science:
- Neuroscience
- Cell Biology
- Physiology
Background:
- The glymphatic system is crucial for central nervous system (CNS) homeostasis, clearing interstitial solutes like amyloid-ß and tau.
- This clearance relies on cerebrospinal fluid (CSF) and interstitial fluid (ISF) exchange within perivascular spaces, facilitated by aquaporin-4 (AQP4) water channels at astrocytic endfeet.
- Glymphatic function declines with aging, neuroinflammation, and vascular changes, contributing to neurodegeneration.
Purpose of the Study:
- To review the mechanisms of glymphatic clearance, focusing on the role of AQP4.
- To explore how signaling pathways and aging impact glymphatic function and contribute to neurodegeneration.
- To discuss potential therapeutic strategies targeting the glymphatic system for neuroprotection.
Main Methods:
- Literature review of glymphatic system function, AQP4 polarization, and related signaling pathways.
- Analysis of factors affecting glymphatic activity, including aging, inflammation, and vascular health.
- Evaluation of current and emerging therapeutic interventions and technologies for modulating glymphatic function.
Main Results:
- AQP4 polarization is essential for efficient glymphatic transport, and its dysregulation is linked to neurodegenerative processes.
- Signaling pathways (NF-kB, Nrf2/keap1, NLRP3 inflammasome) influence AQP4 localization, glial activation, and fluid dynamics, promoting neuroinflammation and oxidative stress.
- Pharmacological and technological advancements offer potential for enhancing glymphatic clearance and neuroprotection.
Conclusions:
- Targeting AQP4 and associated pathways is a promising adjunctive strategy for neurodegenerative diseases.
- Restoring AQP4 polarization and employing anti-inflammatory/antioxidant therapies can improve waste removal and reduce neuroinflammation.
- Further research is needed to address challenges in AQP4 modulation, safety, and human translation.
Related Concept Videos
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
00:49The Blood-brain Barrier
Overview
01:25Aquaporins
Aquaporins or AQPs are a family of integral membrane proteins whose primary function is to transport water, while some called aquaglyceroporins also transport glycerol. In addition, aquaporins have also been suspected to be involved in transporting volatile substances, such as carbon dioxide and ammonia, across membranes. Such AQPs that act as gas channels are often highly expressed in cells involved in the gaseous exchange, such as red blood cells, epithelial cells, and pulmonary capillaries.
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...